Gregory M Glenn Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Gregory M Glenn.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Gregory M Glenn. Gregory M Glenn is President, R&D in NOVAVAX INC ($NVAX) and SVP, Research and Development in NOVAVAX INC ($NVAX) and Chief Scientific Officer in INTERCELL USA, INC. ($IOMI).
Latest Insider Trading Transactions of Gregory M Glenn
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Sep 30 2020 | NVAX | NOVAVAX INC | Glenn Gregory M | President, R&D | Sell | S | 110.97 | 2,343 | 260,012 | 25,358 | 27.7 K to 25.4 K (-8.46 %) |
| Sep 30 2020 | NVAX | NOVAVAX INC | Glenn Gregory M | President, R&D | Sell | S | 109.98 | 8,133 | 894,458 | 27,701 | 35.8 K to 27.7 K (-22.70 %) |
| Sep 30 2020 | NVAX | NOVAVAX INC | Glenn Gregory M | President, R&D | Sell | S | 109.07 | 6,661 | 726,503 | 35,834 | 42.5 K to 35.8 K (-15.67 %) |
| Sep 30 2020 | NVAX | NOVAVAX INC | Glenn Gregory M | President, R&D | Sell | S | 108.20 | 3,739 | 404,549 | 42,496 | 46.2 K to 42.5 K (-8.09 %) |
| Sep 30 2020 | NVAX | NOVAVAX INC | Glenn Gregory M | President, R&D | Sell | S | 107.22 | 276 | 29,593 | 46,235 | 46.5 K to 46.2 K (-0.59 %) |
| Sep 30 2020 | NVAX | NOVAVAX INC | Glenn Gregory M | President, R&D | Buy | M | 5.95 | 25,000 | 148,750 | 46,510 | 21.5 K to 46.5 K (+116.23 %) |
| Sep 29 2020 | NVAX | NOVAVAX INC | Glenn Gregory M | President, R&D | Option Exercise | M | 0.00 | 38,588 | 0 | 0 | |
| Sep 29 2020 | NVAX | NOVAVAX INC | Glenn Gregory M | President, R&D | Payment of Exercise | F | 113.56 | 18,639 | 2,116,645 | 21,510 | 40.1 K to 21.5 K (-46.42 %) |
| Sep 29 2020 | NVAX | NOVAVAX INC | Glenn Gregory M | President, R&D | Buy | M | 0.00 | 38,588 | 0 | 40,149 | 1.6 K to 40.1 K (+2,472.01 %) |
| Aug 26 2020 | NVAX | NOVAVAX INC | Glenn Gregory M | President, R&D | Option Exercise | A | 19.08 | 165,000 | 3,148,200 | 165,000 | |
| Aug 20 2020 | NVAX | NOVAVAX INC | Glenn Gregory M | President, R&D | Option Exercise | M | 46.00 | 13,225 | 608,350 | 18,524 | |
| Aug 20 2020 | NVAX | NOVAVAX INC | Glenn Gregory M | President, R&D | Option Exercise | M | 27.60 | 16,658 | 459,761 | 8,341 | |
| Aug 20 2020 | NVAX | NOVAVAX INC | Glenn Gregory M | President, R&D | Option Exercise | M | 27.00 | 2,733 | 73,791 | 6,017 | |
| Aug 20 2020 | NVAX | NOVAVAX INC | Glenn Gregory M | President, R&D | Option Exercise | M | 27.00 | 8,200 | 221,400 | 550 | |
| Aug 20 2020 | NVAX | NOVAVAX INC | Glenn Gregory M | President, R&D | Option Exercise | M | 36.60 | 4,405 | 161,223 | 0 | |
| Aug 20 2020 | NVAX | NOVAVAX INC | Glenn Gregory M | President, R&D | Option Exercise | M | 25.60 | 7,500 | 192,000 | 0 | |
| Aug 20 2020 | NVAX | NOVAVAX INC | Glenn Gregory M | President, R&D | Option Exercise | M | 50.00 | 3,200 | 160,000 | 0 | |
| Aug 20 2020 | NVAX | NOVAVAX INC | Glenn Gregory M | President, R&D | Gift | G | 0.00 | 1,528 | 0 | 311 | 1.8 K to 311 (-83.09 %) |
| Aug 20 2020 | NVAX | NOVAVAX INC | Glenn Gregory M | President, R&D | Sell | S | 146.58 | 525 | 76,955 | 1,839 | 2.4 K to 1.8 K (-22.21 %) |
| Aug 20 2020 | NVAX | NOVAVAX INC | Glenn Gregory M | President, R&D | Sell | S | 146.00 | 17,151 | 2,504,046 | 2,364 | 19.5 K to 2.4 K (-87.89 %) |
| Aug 20 2020 | NVAX | NOVAVAX INC | Glenn Gregory M | President, R&D | Sell | S | 145.00 | 31,957 | 4,633,765 | 19,515 | 51.5 K to 19.5 K (-62.09 %) |
| Aug 20 2020 | NVAX | NOVAVAX INC | Glenn Gregory M | President, R&D | Sell | S | 143.94 | 6,288 | 905,095 | 51,472 | 57.8 K to 51.5 K (-10.89 %) |
| Aug 20 2020 | NVAX | NOVAVAX INC | Glenn Gregory M | President, R&D | Buy | M | 46.00 | 13,225 | 608,350 | 57,760 | 44.5 K to 57.8 K (+29.70 %) |
| Aug 20 2020 | NVAX | NOVAVAX INC | Glenn Gregory M | President, R&D | Buy | M | 27.60 | 16,658 | 459,761 | 44,535 | 27.9 K to 44.5 K (+59.76 %) |
| Aug 20 2020 | NVAX | NOVAVAX INC | Glenn Gregory M | President, R&D | Buy | M | 27.00 | 2,733 | 73,791 | 27,877 | 25.1 K to 27.9 K (+10.87 %) |
| Aug 20 2020 | NVAX | NOVAVAX INC | Glenn Gregory M | President, R&D | Buy | M | 27.00 | 8,200 | 221,400 | 25,144 | 16.9 K to 25.1 K (+48.39 %) |
| Aug 20 2020 | NVAX | NOVAVAX INC | Glenn Gregory M | President, R&D | Buy | M | 36.60 | 4,405 | 161,223 | 16,944 | 12.5 K to 16.9 K (+35.13 %) |
| Aug 20 2020 | NVAX | NOVAVAX INC | Glenn Gregory M | President, R&D | Buy | M | 25.60 | 7,500 | 192,000 | 12,539 | 5 K to 12.5 K (+148.84 %) |
| Aug 20 2020 | NVAX | NOVAVAX INC | Glenn Gregory M | President, R&D | Buy | M | 50.00 | 3,200 | 160,000 | 5,039 | 1.8 K to 5 K (+174.01 %) |
| Jun 29 2020 | NVAX | NOVAVAX INC | Glenn Gregory M | President, R&D | Option Exercise | A | 5.95 | 66,100 | 393,295 | 66,100 | |
| Jun 29 2020 | NVAX | NOVAVAX INC | Glenn Gregory M | President, R&D | Option Exercise | A | 5.95 | 100,000 | 595,000 | 100,000 | |
| Jun 29 2020 | NVAX | NOVAVAX INC | Glenn Gregory M | President, R&D | Option Exercise | A | 5.95 | 66,100 | 393,295 | 66,100 | |
| Jun 29 2020 | NVAX | NOVAVAX INC | Glenn Gregory M | President, R&D | Option Exercise | A | 5.95 | 100,000 | 595,000 | 100,000 | |
| Jun 22 2020 | NVAX | NOVAVAX INC | Glenn Gregory M | President, R&D | Option Exercise | M | 42.20 | 16,749 | 706,808 | 0 | |
| Jun 22 2020 | NVAX | NOVAVAX INC | Glenn Gregory M | President, R&D | Sell | S | 59.53 | 16,749 | 997,103 | 1,839 | 18.6 K to 1.8 K (-90.11 %) |
| Jun 22 2020 | NVAX | NOVAVAX INC | Glenn Gregory M | President, R&D | Buy | M | 42.20 | 16,749 | 706,808 | 18,588 | 1.8 K to 18.6 K (+910.77 %) |
| Feb 04 2020 | NVAX | NOVAVAX INC | Glenn Gregory M | President, R&D | Buy | P | 3.86 | 1,250 | 4,825 | 1,373 | 123 to 1.4 K (+1,016.26 %) |
| Sep 30 2019 | NVAX | NOVAVAX INC | Glenn Gregory M | President, R&D | Option Exercise | A | 5.95 | 100,000 | 595,000 | 100,000 | |
| Sep 30 2019 | NVAX | NOVAVAX INC | Glenn Gregory M | President, R&D | Option Exercise | A | 5.95 | 66,100 | 393,295 | 66,100 | |
| Sep 30 2019 | NVAX | NOVAVAX INC | Glenn Gregory M | President, R&D | Option Exercise | A | 0.00 | 38,588 | 0 | 38,588 | |
| Sep 16 2019 | NVAX | NOVAVAX INC | Glenn Gregory M | President, R&D | Sell | S | 6.18 | 9,620 | 59,476 | 123 | 9.7 K to 123 (-98.74 %) |
| Sep 10 2019 | NVAX | NOVAVAX INC | Glenn Gregory M | President, R&D | Option Exercise | M | 0.00 | 7,608 | 0 | 0 | |
| Sep 10 2019 | NVAX | NOVAVAX INC | Glenn Gregory M | President, R&D | Payment of Exercise | F | 5.50 | 2,534 | 13,937 | 9,743 | 12.3 K to 9.7 K (-20.64 %) |
| Sep 10 2019 | NVAX | NOVAVAX INC | Glenn Gregory M | President, R&D | Buy | M | 0.00 | 7,608 | 0 | 12,277 | 4.7 K to 12.3 K (+162.95 %) |
| May 13 2019 | NVAX | NOVAVAX INC | Glenn Gregory M | President, R&D | Buy | P | 5.85 | 1,000 | 5,850 | 74,386 | 73.4 K to 74.4 K (+1.36 %) |
| Mar 12 2019 | NVAX | NOVAVAX INC | Glenn Gregory M | President, R&D | Option Exercise | A | 0.00 | 76,083 | 0 | 76,083 | |
| Mar 12 2019 | NVAX | NOVAVAX INC | Glenn Gregory M | President, R&D | Option Exercise | A | 0.00 | 152,166 | 0 | 152,166 | |
| Feb 04 2019 | NVAX | NOVAVAX INC | Glenn Gregory M | President, R&D | Buy | P | 0.88 | 13,168 | 11,588 | 73,386 | 60.2 K to 73.4 K (+21.87 %) |
| Dec 14 2018 | NVAX | NOVAVAX INC | Glenn Gregory M | President, R&D | Option Exercise | A | 2.30 | 635,000 | 1,460,500 | 635,000 | |
| Aug 01 2018 | NVAX | NOVAVAX INC | Glenn Gregory M | President, R&D | Buy | P | 0.88 | 13,007 | 11,446 | 60,218 | 47.2 K to 60.2 K (+27.55 %) |
| May 15 2018 | NVAX | NOVAVAX INC | Glenn Gregory M | President, R&D | Buy | P | 1.64 | 19,900 | 32,636 | 47,211 | 27.3 K to 47.2 K (+72.86 %) |
| May 15 2018 | NVAX | NOVAVAX INC | Glenn Gregory M | President, R&D | Buy | P | 1.64 | 100 | 164 | 27,311 | 27.2 K to 27.3 K (+0.37 %) |
| Feb 01 2018 | NVAX | NOVAVAX INC | Glenn Gregory M | President, R&D | Buy | P | 0.88 | 12,784 | 11,250 | 27,211 | 14.4 K to 27.2 K (+88.61 %) |
| Dec 19 2017 | NVAX | NOVAVAX INC | Glenn Gregory M | President, R&D | Option Exercise | A | 1.38 | 500,000 | 690,000 | 500,000 | |
| Nov 13 2017 | NVAX | NOVAVAX INC | Glenn Gregory M | President, R&D | Buy | P | 1.13 | 10,000 | 11,300 | 14,427 | 4.4 K to 14.4 K (+225.89 %) |
| Dec 07 2016 | NVAX | NOVAVAX INC | Glenn Gregory M | President, R&D | Buy | P | 1.45 | 1,000 | 1,446 | 4,427 | 3.4 K to 4.4 K (+29.18 %) |
| Nov 16 2016 | NVAX | NOVAVAX INC | Glenn Gregory M | President, R&D | Option Exercise | A | 1.35 | 175,000 | 236,250 | 175,000 | |
| Nov 16 2016 | NVAX | NOVAVAX INC | Glenn Gregory M | President, R&D | Option Exercise | A | 1.35 | 175,000 | 236,250 | 175,000 | |
| Sep 22 2016 | NVAX | NOVAVAX INC | Glenn Gregory M | President, R&D | Buy | P | 1.65 | 1,000 | 1,649 | 3,427 | 2.4 K to 3.4 K (+41.20 %) |
| Mar 17 2016 | NVAX | NOVAVAX INC | Glenn Gregory M | President, R&D | Option Exercise | A | 4.99 | 350,000 | 1,746,500 | 350,000 | |
| Feb 01 2016 | NVAX | NOVAVAX INC | Glenn Gregory M | SVP, Research and D ... | Buy | P | 4.38 | 2,369 | 10,376 | 2,427 | 58 to 2.4 K (+4,084.48 %) |
| Dec 18 2015 | NVAX | NOVAVAX INC | Glenn Gregory M | SVP, Research and D ... | Option Exercise | M | 1.83 | 61,886 | 113,251 | 88,114 | |
| Dec 18 2015 | NVAX | NOVAVAX INC | Glenn Gregory M | SVP, Research and D ... | Sell | S | 8.58 | 61,886 | 530,697 | 58 | 61.9 K to 58 (-99.91 %) |
| Dec 18 2015 | NVAX | NOVAVAX INC | Glenn Gregory M | SVP, Research and D ... | Buy | M | 1.83 | 61,886 | 113,251 | 61,944 | 58 to 61.9 K (+106,700.00 %) |
| Aug 26 2015 | NVAX | NOVAVAX INC | Glenn Gregory M | SVP, Research and D ... | Gift | G | 0.00 | 1,100 | 0 | 58 | 1.2 K to 58 (-94.99 %) |
| Aug 20 2015 | NVAX | NOVAVAX INC | Glenn Gregory M | SVP, Research and D ... | Option Exercise | M | 2.11 | 15,000 | 31,650 | 335,000 | |
| Aug 20 2015 | NVAX | NOVAVAX INC | Glenn Gregory M | SVP, Research and D ... | Sell | S | 13.52 | 15,000 | 202,743 | 1,158 | 16.2 K to 1.2 K (-92.83 %) |
| Aug 20 2015 | NVAX | NOVAVAX INC | Glenn Gregory M | SVP, Research and D ... | Buy | M | 2.11 | 15,000 | 31,650 | 16,158 | 1.2 K to 16.2 K (+1,295.34 %) |
| Aug 04 2015 | NVAX | NOVAVAX INC | Glenn Gregory M | SVP, Research and D ... | Buy | P | 2.28 | 892 | 2,034 | 1,158 | 266 to 1.2 K (+335.34 %) |
| Mar 16 2015 | NVAX | NOVAVAX INC | Glenn Gregory M | SVP, Research and D ... | Gift | G | 0.00 | 600 | 0 | 266 | 866 to 266 (-69.28 %) |
| Mar 09 2015 | NVAX | NOVAVAX INC | Glenn Gregory M | SVP, Research and D ... | Option Exercise | A | 8.94 | 300,000 | 2,682,000 | 300,000 | |
| Jan 04 2008 | IOMI | INTERCELL USA, INC ... | Glenn Gregory M | Chief Scientific Of ... | Option Exercise | A | 1.04 | 50,000 | 52,000 | 50,000 | |
| Sep 10 2007 | IOMI | INTERCELL USA, INC ... | Glenn Gregory M | Chief Scientific Of ... | Buy | P | 1.89 | 385 | 727 | 84,123 | 83.7 K to 84.1 K (+0.46 %) |
| Aug 20 2007 | IOMI | INTERCELL USA, INC ... | Glenn Gregory M | Chief Scientific Of ... | Buy | P | 1.73 | 2,000 | 3,460 | 83,738 | 81.7 K to 83.7 K (+2.45 %) |
| Aug 15 2007 | IOMI | INTERCELL USA, INC ... | Glenn Gregory M | Chief Scientific Of ... | Buy | P | 1.79 | 10,000 | 17,900 | 81,738 | 71.7 K to 81.7 K (+13.94 %) |
| Aug 15 2007 | IOMI | INTERCELL USA, INC ... | Glenn Gregory M | Chief Scientific Of ... | Gift | G | 0.00 | 10,000 | 0 | 71,738 | 81.7 K to 71.7 K (-12.23 %) |
| Aug 15 2007 | IOMI | INTERCELL USA, INC ... | Glenn Gregory M | Chief Scientific Of ... | Gift | G | 0.00 | 2,000 | 0 | 81,738 | 83.7 K to 81.7 K (-2.39 %) |
| Aug 15 2007 | IOMI | INTERCELL USA, INC ... | Glenn Gregory M | Chief Scientific Of ... | Gift | G | 0.00 | 1,000 | 0 | 83,738 | 84.7 K to 83.7 K (-1.18 %) |
| Mar 07 2007 | IOMI | INTERCELL USA, INC ... | Glenn Gregory M | Chief Scientific Of ... | Option Exercise | A | 4.95 | 125,000 | 618,750 | 665,383 | |
| Feb 17 2006 | IOMI | INTERCELL USA, INC ... | Glenn Gregory M | Chief Scientific Of ... | Option Exercise | A | 5.51 | 125,000 | 688,750 | 540,383 | |
| Feb 16 2006 | IOMI | INTERCELL USA, INC ... | Glenn Gregory M | Chief Scientific Of ... | Buy | P | 5.72 | 1,000 | 5,720 | 112,738 | 111.7 K to 112.7 K (+0.89 %) |